Structures by: Rakib E. M.
Total: 51
Ethyl 10α-hydroxy-4,9-dimethyl-14-oxo-3,8,15-trioxatetracyclo[10.3.0.0^2,4^.0^7,9^]pentadecane-13-spiro-5-pyrazole-3'-carboxylate
C25H29ClN2O7
IUCrData (2020) 5, 7 x200945
a=9.2324(3)Å b=11.1656(4)Å c=23.3497(8)Å
α=90° β=90° γ=90°
9α-Hydroxy-4,8-dimethyl-3-phenyl-3,14-dioxatricyclo[9.3.0.0^2,4^]tetradec-7-en-13-one-12-spiro-5'-isoxazole monohydrate
C22H25NO5,H2O
IUCrData (2019) 4, 10 x191408
a=9.8947(4)Å b=10.6554(4)Å c=19.0286(8)Å
α=90° β=90° γ=90°
1-Allyl-5-(2,5-dimethyl-1<i>H</i>-pyrrol-1-yl)-1<i>H</i>-indazole
C16H17N3
IUCrData (2016) 1, 7 x161121
a=7.5140(2)Å b=10.3737(3)Å c=17.8484(5)Å
α=90° β=90° γ=90°
Ethyl 2-(6-nitro-2<i>H</i>-indazol-2-yl)acetate
C11H11N3O4
IUCrData (2016) 1, 7 x161074
a=31.808(3)Å b=4.6312(4)Å c=19.0381(16)Å
α=90° β=122.839(3)° γ=90°
Ethyl (<i>E</i>)-2-(2,7-dimethyl-5-oxo-4<i>H</i>,5<i>H</i>-pyrano[4,3-<i>b</i>]pyran-4-ylidene)acetate
C14H14O5
IUCrData (2017) 2, 2 x170208
a=9.5679(12)Å b=11.4330(13)Å c=12.7993(15)Å
α=90° β=108.257(4)° γ=90°
Ethyl 2-(2-methyl-4-nitro-1<i>H</i>-imidazol-1-yl)acetate
C8H11N3O4
IUCrData (2016) 1, 4 x160588
a=4.4793(2)Å b=10.3596(5)Å c=21.5724(11)Å
α=90° β=90° γ=90°
(<i>Z</i>)-3-Allyl-5-(4-fluorobenzylidene)-2-sulfanylidenethiazolidin-4-one
C13H10FNOS2
IUCrData (2016) 1, 8 x161236
a=4.7764(10)Å b=11.750(3)Å c=13.067(3)Å
α=109.917(10)° β=99.766(11)° γ=101.710(10)°
4-Methoxy-<i>N</i>-(1-methyl-1<i>H</i>-indazol-7-yl)benzenesulfonamide hemihydrate
C15H15N3O3S,0.5(H2O)
IUCrData (2017) 2, 5 x170645
a=8.3013(5)Å b=13.1934(8)Å c=15.3583(9)Å
α=103.241(3)° β=105.470(3)° γ=93.046(3)°
(<i>Z</i>)-3-Allyl-5-(3-methoxybenzylidene)-2-sulfanylidene-1,3-thiazolidin-4-one
C14H13NO2S2
IUCrData (2016) 1, 1 x160052
a=6.9841(14)Å b=8.3241(18)Å c=13.116(3)Å
α=89.276(9)° β=75.614(9)° γ=72.095(10)°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=7.0748(4)Å b=8.1131(4)Å c=16.9559(9)Å
α=90° β=90° γ=90°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=6.5388(7)Å b=18.888(2)Å c=15.6064(18)Å
α=90° β=90° γ=90°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=9.2170(17)Å b=16.827(3)Å c=6.6121(13)Å
α=90° β=109.778(4)° γ=90°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=9.5041(12)Å b=10.9669(14)Å c=9.1780(12)Å
α=90° β=94.857(3)° γ=90°
C10H8N4O2
C10H8N4O2
New Journal of Chemistry (2019) 43, 36 14355
a=7.6034(4)Å b=14.7108(7)Å c=8.7184(4)Å
α=90° β=100.023(2)° γ=90°
2(C32H26N6O2),3.5(CHCl3),0.5(C3H6O)
2(C32H26N6O2),3.5(CHCl3),0.5(C3H6O)
New J. Chem. (2015) 39, 9 6738
a=11.4963(12)Å b=16.0196(17)Å c=20.763(2)Å
α=78.971(4)° β=85.227(5)° γ=81.247(4)°
3-{1-[(1-Allyl-1<i>H</i>-indazol-6-yl)amino]ethylidene}-6-methyl-2<i>H</i>-pyran-2,4(3<i>H</i>)-dione
C18H17N3O3
Acta Crystallographica Section E (2014) 70, 12 o1256
a=6.7708(11)Å b=10.5761(17)Å c=11.9643(17)Å
α=88.239(9)° β=81.123(9)° γ=79.140(9)°
2-(4-Methylbenzylidene)malononitrile
C11H8N2
Acta Crystallographica Section E (2014) 70, 12 o1263
a=7.0043(5)Å b=7.5270(5)Å c=9.5396(6)Å
α=106.757(4)° β=96.592(4)° γ=105.204(4)°
3-Chloro-1-methyl-5-nitro-1<i>H</i>-indazole
C8H6ClN3O2
Acta Crystallographica Section E (2015) 71, 11 o834-o835
a=3.8273(2)Å b=14.678(6)Å c=15.549(6)Å
α=90° β=96.130(9)° γ=90°
<i>N</i>-(1-Acetyl-3-chloro-1<i>H</i>-indazol-6-yl)-4-methoxybenzenesulfonamide
C16H14ClN3O4S
Acta Crystallographica Section E (2015) 71, 12 o914-o915
a=13.9664(6)Å b=6.4300(3)Å c=19.6155(9)Å
α=90° β=107.2270(10)° γ=90°
(<i>Z</i>)-3-Allyl-5-(3-bromobenzylidene)-2-sulfanylidene-1,3-thiazolidin-4-one
C13H10BrNOS2
Acta Crystallographica Section E (2015) 71, 12 o1010-o1011
a=5.4044(6)Å b=11.2306(13)Å c=11.7966(13)Å
α=80.100(5)° β=84.912(6)° γ=76.732(6)°
(<i>Z</i>)-3-Allyl-5-(4-chlorobenzylidene)-2-sulfanylidene-1,3-thiazolidin-4-one
C13H10ClNOS2
Acta Crystallographica Section E (2015) 71, 12 o1012
a=7.6197(8)Å b=7.9849(7)Å c=13.0624(14)Å
α=77.600(5)° β=77.996(5)° γ=61.954(4)°
(<i>Z</i>)-3-Allyl-5-(4-methylbenzylidene)-2-sulfanylidene-1,3-thiazolidin- 4-one
C14H13NOS2
Acta Crystallographica Section E (2015) 71, 12 o906-o907
a=7.3606(4)Å b=8.8342(6)Å c=11.3134(7)Å
α=109.736(2)° β=95.380(2)° γ=96.502(2)°
(<i>E</i>)-3-Allyl-2-sulfanylidene-5-[(thiophen-2-yl)methylidene]thiazolidin-4-one
C11H9NOS3
Acta Crystallographica Section E (2015) 71, 6 o433-o434
a=6.7342(2)Å b=7.3762(2)Å c=13.2917(5)Å
α=79.386(2)° β=80.104(2)° γ=68.9080(10)°
<i>N</i>-(2-Allyl-4-ethoxy-2<i>H</i>-indazol-5-yl)-4-methylbenzenesulfonamide
C19H21N3O3S
Acta Crystallographica Section E (2014) 70, 5 o624
a=26.0808(5)Å b=7.9335(2)Å c=21.1573(4)Å
α=90.00° β=122.8390(10)° γ=90.00°
<i>N</i>-(1-Allyl-3-chloro-4-ethoxy-1<i>H</i>-indazol-5-yl)-4-methylbenzenesulfonamide
C19H20ClN3O3S
Acta Crystallographica Section E (2014) 70, 6 o653
a=10.0345(2)Å b=10.5208(2)Å c=10.7237(2)Å
α=71.5610(10)° β=69.6010(10)° γ=83.0390(10)°
<i>N</i>-(3-Chloro-4-ethoxy-1-methyl-1<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide
C17H18ClN3O4S
Acta Crystallographica Section E (2014) 70, 6 o679
a=8.5296(9)Å b=8.6165(9)Å c=12.9821(14)Å
α=91.810(6)° β=102.566(5)° γ=100.514(5)°
<i>N</i>-(7-Ethoxy-1<i>H</i>-indazol-4-yl)-4-methylbenzenesulfonamide
C16H17N3O3S
Acta Crystallographica Section E (2011) 67, 6 o1354
a=16.2579(4)Å b=5.02910(10)Å c=20.4551(5)Å
α=90.00° β=97.2690(10)° γ=90.00°
6-Methyl-2-phenyl-4,5-dihydropyridazin-3(2<i>H</i>)-one
C11H12N2O
Acta Crystallographica Section E (2011) 67, 7 o1709
a=6.4151(2)Å b=7.9010(2)Å c=10.1888(3)Å
α=90.00° β=106.6070(10)° γ=90.00°
<i>N</i>-[7-Ethoxy-1-(prop-2-en-1-yl)-1<i>H</i>-indazol-4-yl]-4- methylbenzenesulfonamide
C19H21N3O3S
Acta Crystallographica Section E (2011) 67, 7 o1561
a=8.2208(3)Å b=10.4985(4)Å c=11.9655(5)Å
α=108.814(2)° β=92.346(2)° γ=107.500(2)°
<i>N</i>-[7-Ethoxy-2-(prop-2-en-1-yl)-2<i>H</i>-indazol-6-yl]-4- methylbenzenesulfonamide
C19H21N3O3S
Acta Crystallographica Section E (2011) 67, 12 o3211
a=10.1459(7)Å b=9.9506(7)Å c=18.3720(13)Å
α=90.00° β=95.097(3)° γ=90.00°
<i>N</i>-(2-Formylphenyl)-4-methoxy-<i>N</i>-(4- methoxyphenylsulfonyl)benzenesulfonamide
C21H19NO7S2
Acta Crystallographica Section E (2011) 67, 12 o3304
a=9.0559(3)Å b=25.8904(10)Å c=9.3844(3)Å
α=90.00° β=103.423(2)° γ=90.00°
<i>N</i>-(3-Chloro-1<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide
C14H12ClN3O3S
Acta Crystallographica Section E (2013) 69, 11 o1632
a=16.1229(5)Å b=10.0562(3)Å c=9.7955(2)Å
α=90.00° β=105.3880(10)° γ=90.00°
<i>N</i>-(1<i>H</i>-Indazol-5-yl)-4-methoxybenzenesulfonamide
C14H13N3O3S
Acta Crystallographica Section E (2013) 69, 11 o1702
a=8.9996(4)Å b=7.1999(3)Å c=21.3728(10)Å
α=90.00° β=91.794(3)° γ=90.00°
<i>N</i>-(3-Chloro-1-methyl-1<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide
C15H14ClN3O3S
Acta Crystallographica Section E (2014) 70, 9 o983-o984
a=8.20230(10)Å b=10.6312(2)Å c=10.8957(2)Å
α=117.5230(10)° β=93.0950(10)° γ=103.1660(10)°
<i>N</i>-(3-Chloro-1-methyl-1<i>H</i>-indazol-5-yl)-4-methylbenzenesulfonamide
C15H14ClN3O2S
Acta Crystallographica Section E (2014) 70, 2 o181
a=8.4580(13)Å b=34.920(6)Å c=10.8333(17)Å
α=90.00° β=97.226(7)° γ=90.00°
<i>N</i>-(1-Allyl-1<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide hemihydrate
2(C17H17N3O3S),H2O
Acta Crystallographica Section E (2013) 69, 10 o1589-o1590
a=8.2099(7)Å b=13.8928(12)Å c=15.0495(14)Å
α=90.00° β=92.327(3)° γ=90.00°
Ethyl 3-[7-ethoxy-6-(4-methoxybenzenesulfonamido)-2<i>H</i>-indazol-2-yl]propanoate
C21H25N3O6S
Acta Crystallographica Section E (2012) 68, 4 o931
a=9.1163(4)Å b=10.9161(5)Å c=11.2959(5)Å
α=77.259(2)° β=77.364(2)° γ=88.562(2)°
Ethyl 3-[6-(4-methoxybenzenesulfonamido)-2<i>H</i>-indazol-2-yl]propanoate monohydrate
C19H21N3O5S,H2O
Acta Crystallographica Section E (2013) 69, 2 o190-o191
a=9.0248(3)Å b=8.7602(3)Å c=13.1792(4)Å
α=90.00° β=101.062(2)° γ=90.00°
5,11-Ditosyl-5<i>H</i>,11<i>H</i>-dibenzo[<i>b</i>,<i>f</i>][1,5]diazocine-6,12-dione acetic acid hemisolvate
C28H22N2O6S2,0.5(C2H4O2)
Acta Crystallographica Section E (2013) 69, 4 o614-o615
a=8.6933(11)Å b=11.1746(18)Å c=14.8051(19)Å
α=87.042(4)° β=74.370(5)° γ=75.097(4)°
1-(4-Methylphenylsulfonyl)-5,6-dinitro-1<i>H</i>-indazole
C14H10N4O6S
Acta Crystallographica Section E (2014) 70, 1 o101
a=7.4125(3)Å b=8.5371(3)Å c=13.0825(5)Å
α=90.401(2)° β=95.707(2)° γ=111.302(2)°
6,6'-Dinitro-1,1'-(ethane-1,2-diyl)di(1<i>H</i>-indazole)
C16H12N6O4
Acta Crystallographica Section E (2014) 70, 4 o390
a=9.410(5)Å b=12.064(5)Å c=14.804(4)Å
α=90.00° β=109.01(2)° γ=90.00°
1-Methyl-2-methylsulfanyl-6-nitro-1<i>H</i>-benzimidazole
C9H9N3O2S
Acta Crystallographica Section E (2014) 70, 4 o407
a=11.7213(4)Å b=11.8991(4)Å c=7.3025(3)Å
α=90.00° β=103.5230(10)° γ=90.00°
4-Methyl-<i>N</i>-(1-methyl-1<i>H</i>-indazol-5-yl)benzenesulfonamide
C15H15N3O2S
Acta Crystallographica Section E (2013) 69, 9 o1471
a=8.0026(3)Å b=12.8195(4)Å c=14.1321(4)Å
α=90.00° β=91.602(2)° γ=90.00°
4-Methoxy-<i>N</i>-(1-methyl-1<i>H</i>-indazol-5-yl)benzenesulfonamide
C15H15N3O3S
Acta Crystallographica Section E (2013) 69, 9 o1398
a=10.1069(3)Å b=13.6178(3)Å c=10.8530(2)Å
α=90.00° β=90.777(2)° γ=90.00°
1-Allyl-3-chloro-5-nitro-1<i>H</i>-indazole
C10H8ClN3O2
Acta Crystallographica Section E (2013) 69, 9 o1410
a=13.3025(6)Å b=11.2505(5)Å c=7.3092(3)Å
α=90.00° β=91.343(2)° γ=90.00°
<i>N</i>-(2-Allyl-4-chloro-2<i>H</i>-indazol-5-yl)-4-methoxybenzenesulfonamide hemihydrate
C17H16ClN3O3S,0.5(H2O)
Acta Crystallographica Section E (2013) 69, 8 o1353
a=23.5515(9)Å b=8.9081(3)Å c=20.8278(8)Å
α=90.00° β=122.628(2)° γ=90.00°
2-Allyl-7-nitro-2<i>H</i>-indazole
C10H9N3O2
Acta Crystallographica Section E (2013) 69, 11 o1603-o1604
a=8.1848(3)Å b=8.3253(4)Å c=16.3194(6)Å
α=84.168(2)° β=85.653(2)° γ=60.843(2)°
<i>N</i>-(1-Allyl-1<i>H</i>-indazol-5-yl)-4-methylbenzenesulfonamide
C17H17N3O2S
Acta Crystallographica Section E (2013) 69, 12 o1847
a=8.8200(4)Å b=10.4769(5)Å c=19.7407(10)Å
α=80.2110(10)° β=78.9840(10)° γ=69.7840(10)°
Ethyl 3-[7-(<i>N</i>-acetyl-4-methoxybenzenesulfonamido)-3-chloro-2<i>H</i>-indazol-2-yl]propionate
C21H22ClN3O6S
Acta Crystallographica Section E (2014) 70, 3 o307-o308
a=9.1442(3)Å b=9.4376(4)Å c=14.0931(6)Å
α=108.262(2)° β=96.017(2)° γ=103.313(2)°
<i>N</i>-(1-Allyl-3-chloro-4-ethoxy-1<i>H</i>-indazol-5-yl)-4-\ methoxybenzenesulfonamide
C19H20ClN3O4S
Acta Crystallographica Section E (2014) 70, 9 o1029-o1030
a=8.2699(7)Å b=13.1235(12)Å c=10.0026(9)Å
α=90.00° β=110.379(5)° γ=90.00°
<i>N</i>-(1-Allyl-3-chloro-1<i>H</i>-indazol-5-yl)-4-methylbenzenesulfonamide
C17H16ClN3O2S
Acta Crystallographica Section E (2014) 70, 9 o1041-o1042
a=8.1736(12)Å b=22.504(4)Å c=19.279(3)Å
α=90.00° β=90.00° γ=90.00°